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den Brandt PA. Etiology of atopy in infancy: The KOALA Birth Co-
hort Study.
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The aim of the KOALA Birth Cohort Study in the Netherlands is to
identify factors that inﬂuence the clinical expression of atopic disease
with a main focus on lifestyle (e.g., anthroposophy, vaccinations,
antibiotics, dietary habits, breastfeeding and breast milk composition,
intestinal microﬂora composition, infections during the ﬁrst year of life,
and gene–environment interaction). The recruitment of pregnant
women started in October 2000. First, participants with conventional
lifestyles (n ¼ 2343) were retrieved from an ongoing prospective cohort
study (n ¼ 7020) on pregnancy-related pelvic girdle pain. In addition,
pregnant women (n ¼ 491) with alternative lifestyles with regard to
child rearing practices, dietary habits (organic, vegetarian), vaccination
schemes and/or use of antibiotics, were recruited through organic food
shops, anthroposophic doctors and midwives, Steiner schools, and
dedicated magazines. All participants were enrolled between 14 and
18 wk of gestation and completed an intake questionnaire on family
history of atopy and infant care intentions. Documentation of other
relevant variables started in the pregnant mother and covered the ﬁrst
and third trimester as well as early childhood by repeated questionnaires
at 14–18, 30, and 34 wk of gestation and 3, 7, 12, and 24 months post-
partum. A subgroup of participants, including both conventional and
alternative lifestyles, was asked to consent to maternal blood sampling,
breast milk and a faecal sample of the infant at 1 month post-partum,
capillary blood at age 1 yr, venous blood and observation of manifes-
tation of atopic dermatitis during home visits at the age of 2 yr (using
the UK working party criteria and the severity scoring of atopic der-
matitis index), and buccal swabs for DNA isolation from child–parent
trios. From the start, ethical approval and informed consent procedures
included gene–environment interaction studies. Follow-up at 3 and
7 months post-partum was completed with high response rates
(respectively 90% and 88% in the conventional group, and 97% and
97% in the alternative group). The home visits at 2 yr of age will be
completed in 2005. Preliminary results show that we have succeeded in
recruiting a large population with various lifestyle choices with a fairly
large contrast with regard to dietary habits (including organic foods,
vegetarian diet), vaccination schemes and/or use of antibiotics. We have
also been able to collect a large number of faecal samples (n ¼ 1176)
and capillary blood samples at age 1 yr (n ¼ 956). Furthermore, a large
proportion of the participants have consented with genetic studies. Mid
2006 we expect to report our ﬁrst results on the relationship between the
various exposures in early life and childhood atopy. An outline of the
focus and design of the KOALA Birth Cohort Study is presented.
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The prevalence of atopic diseases such as asthma,
atopic eczema, and allergic rhinitis has increased
over the past decades and currently 30% of the
children in western societies show atopic symp-
toms (1). Atopic disease is thus an important
public health problem, and preventive measures
would be beneﬁciary. Despite years of research,
little is yet understood concerning the etiologic
pathways leading to these diseases. Atopic dis-
orders typically run in families and therefore,
genetic factors are supposed to be important (2).
However, it is not likely that the frequency of
polymorphisms in genes associated with the
development of atopic diseases like asthma and
eczema would have changed within the same two
generations experiencing the increasing preval-
ence of atopy. Because of a change in environ-
mental exposures, the population fraction
exposed to important environmental inﬂuences
may have changed, leading to an increased
incidence of the expression of the atopic pheno-
type in previously unaﬀected but genetically
susceptible individuals (2). An already existing
genetic susceptible proportion of the population
may have either become increasingly exposed to
certain environmental risk factors which have
become increasingly prevalent (3) or have
become less exposed to various protective factors
(4). Initially, in epidemiologic studies concerning
atopy risk factors deserved most attention (e.g.,
dust mites, and ambient air pollution). More
recently, however, the inﬂuence of various poten-
tially protective factors (early microbial expo-
sure, infections, pets, various immunologic and
dietary factors in breast milk) has been empha-
sized. The role of a protective lifestyle was
highlighted by a study reporting that growing
up in anthroposophic families was protective
against developing atopic disease (5). An
anthroposophic lifestyle diﬀers in many respects
from living a conventional lifestyle, such as
diﬀerent dietary habits (e.g., a higher intake of
fermented vegetables, consumption of mainly
organic or biodynamically produced food, and a
vegetarian diet), and restricted use of antibiotics
and vaccinations. This lifestyle pattern reﬂects in
part the traditional lifestyle of western societies
several decades ago when the prevalence of atopy
was lower than today but main characteristics
may diﬀer between countries.
This paper describes the design of the KOALA
Birth Cohort Study, the Netherlands. KOALA is
(in Dutch) an acronym for Child, Parent and
health: Lifestyle and Genetic constitution. The
aim of the KOALA study is to identify factors
that inﬂuence the clinical expression of atopic
disease with a main focus on lifestyle.
Lifestyle factors and development of atopy
Studies performed in diﬀerent geographic areas
have shown that a western lifestyle predisposes to
atopic disease (1). We investigate the role of
vaccinations, antibiotics, diﬀerent dietary habits
(breastfeeding, organic foods, and vegetarian
diet) and alternative child rearing practices
(anthroposophy) in early life in the subsequent
development of atopy.
Although several studies have suggested that
breastfeeding is protective, results of the avail-
able studies so far are inconsistent (6, 7). Breast
milk contains immunologic factors [e.g., cytok-
ines, chemokines, immunoglobulin A (IgA) anti-
bodies] and dietary factors such as fatty acids
that can be beneﬁcial for the recipient infant
(8–11). We aim to investigate whether immuno-
logic factors and fatty acid patterns in breast
milk depend on the mother’s atopic constitution.
In addition, the role of essential fatty acids and
immunologic factors on atopic outcomes in
breast-fed children is studied.
The composition of the intestinal microﬂora in
early life is strongly inﬂuenced by dietary, envi-
ronmental, and lifestyle characteristics. Alm et al.
(12) showed that lifestyle factors associated with
an anthroposophic way of life correlated with
diﬀerences in infant gut ﬂora. These studies
indicate that the composition of gut ﬂora might
inﬂuence the development and priming of the
immune system, which in turn could aﬀect the risk
of atopy (13, 14). In the KOALA study, we
determine gut ﬂora composition in infants at the
age of 1 month. Also the relation with the devel-
opment of atopy later in life will be investigated.
To determine this microbial ﬂora, we are currently
developing several species and genus speciﬁc real-
time PCR assays. This culture-independent tech-
nique can be used on both fresh and frozen
samples and overcomes many of the problems
associated with traditional bacteriologic cultur-
ing, such as the low sensitivity and reproducibility
and the inability to detect non-culturable bacteria.
Another aim in the KOALA study is to
address the role of infections and vaccinations
in early life in the subsequent development of
allergies, the so-called hygiene hypothesis. We
look at the role of gastrointestinal infections in
relation to development of atopic dermatitis and
food allergy in the ﬁrst year of life and focus on
infections that occur at young age and that have
been related in some way to the development of
atopic diseases (rotavirus, norovirus, Bordetella
pertussis and parasites Toxocara and Ascaris).
Infection will be assessed through the
determination of speciﬁc antibodies in capillary
Kummeling et al.
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blood samples collected at 1 yr of age. By
combining the sampling dates with data from
routine surveillance on seasonal occurrence of
the diseases under study, the most probable
period of infection will be mapped to 6-month
intervals.
Familial pre-disposition has historically been
identiﬁed as an important risk factor in asthma
and atopic diseases (15). However, it is diﬃcult
to discriminate between the eﬀect of genes and
the eﬀect of environmental factors, because both
cluster in families. Therefore, in order to under-
stand the familial aggregation of atopic diseases,
genes, and environmental factors should be
studied in combination. The KOALA study
aims at selecting genes important to the regula-
tion of the innate immune system. Examples of
candidate genes are polymorphisms in CD14,
toll-like receptors, MYD88, INF-c, IL-12, IL-10,
IL-4, and IL-13 genes. Buccal swabs from
parent–child trios are collected for DNA isola-
tion. Adequate power for gene–environment
interaction is assured by combining data from
the KOALA study with two other cohorts in the
Netherlands.
Design
The KOALA study is a prospective birth cohort
study. Pregnant women have been recruited
from an ongoing prospective cohort study (n ¼
7020) on pregnancy-related pelvic girdle pain
(PPGP study) among pregnant women in the
Netherlands (16). Enrolment started in October
2000 and aimed at women at 14–16 wk of
gestation. At 34 wk of gestation, PPGP subjects
were asked to participate in the KOALA study
(conventional participants). Additionally,
recruitment of pregnant women with alternative
lifestyles (alternative participants) started
through several alternative recruitment chan-
nels, i.e., posters in organic shops, anthropo-
sophic doctors and midwives, anthroposophic
under-ﬁve clinics, Steiner schools, and maga-
zines for special interest groups. Like for the
PPGP cohort, in this alternative population
pregnant women were enrolled at 14–18 wk of
gestation. In order to evaluate selective partici-
pation of PPGP participants in the KOALA
study, we took a short recruitment question-
naire on family history of allergy and asthma
and on infant care intentions [use of medication
or vaccinations, dietary habits (regular, organic,
and vegetarian) and intention to breastfeed] at
the time of enrolment.
Perinatal determinants and exposure data on
determinants of atopy (hygiene, infections,
nutritional data, child rearing, and other lifestyle
characteristics) were collected for all members of
the cohort by repeated questionnaires during
pregnancy and during the ﬁrst 2 yr of the infant’s
life at 3, 7, 12, and 24 months post-partum.
Follow-up at 3 and 7 months post-partum was
completed with high response rates (respectively
90% and 88% for conventional participants, and
97% and 97% for alternative participants).
Participants recruited from January 2002
onwards (conventional and alternative) were
asked to consent to maternal blood sampling
(n ¼ 1355) around 36 wk of gestation (for deter-
mination of IgE) (subcohort named KOALA-
SUB). KOALA-SUB participants were also
asked to consent to sampling infant’s feces at
1 month post-partum (for determination of gut
ﬂora composition; n ¼ 1176) and breast milk at
1 month post-partum (for measurement of
immunologic markers and fatty acids; n ¼ 317).
Furthermore, they were asked to consent to
collecting of capillary blood at the age of 1 yr
(n ¼ 956) and venous blood at the age (collected
at the time of writing) of 2 yr for the determin-
ation of infection serology and the measurement
of total and speciﬁc IgE levels. Buccal swabs
from trios (the child and both parents) as source
of DNA for genetic analysis were collected at the
time of writing. All biosamples have been stored
frozen in a biobank to which access is granted to
the participating research groups following a
review of protocols by the KOALA steering
committee.
When the child is 2 yr, the main atopic
outcomes are eczema, total and speciﬁc IgE and
food allergy. Questionnaires sent to all partici-
pants around the child’s age of 7, 12, and
24 months include the International Study of
Asthma and Allergies in Childhood question-
naire (17).
At 2 yr of age, children participating in
KOALA-SUB are visited at home. During these
home visits manifestations of atopic dermatitis
are observed using the UK working party criteria
for atopic dermatitis (18–20) and severity of
atopic dermatitis is scored using the severity
scoring of atopic dermatitis index (21). Further-
more, total and speciﬁc IgE is assessed at age 1
and 2 yr in KOALA-SUB participants. The
home visits at 2 yr of age will be completed in
2005.
All participants had signed informed consent.
Ethical approval was obtained from the medical
ethics committee of the Maastricht University/
University Hospital of Maastricht. Genetic test-
ing was also included in the medical ethical
committee and informed consent procedures.
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Definitions
In the recruitment questionnaire, the questions
on family history of allergy and asthma were
phrased as follows: Did you ever had allergic
complaints such as eczema, hay fever, house dust
(mite) allergy and/or food allergy?, and Did you
ever had asthma or asthmatic bronchitis?, for
both parents separately. Both questions could be
answered by yes, no or unknown. We deﬁned
a family history of allergy or asthma as present
(yes) in one or both parents.
Questions on infant care intentions were
phrased as: Do you adhere to a certain philos-
ophy of life for which you: (i) consciously restrict
use of medication (e.g., antibiotics) (yes, no,
unknown), (ii) consciously have lower vaccin-
ation uptake (yes, no, unknown), (iii) consciously
choose an organic, vegetarian or macrobiotic diet
(yes, no, unknown) than most other Dutch
people? and How do you intent to feed your
baby? (breastfeeding, formulae, both, do not
know).
At 7 months post-partum, we asked parents
whether they had their child vaccinated by the
standard Dutch Vaccination Program Scheme or
whether they made use of an alternative scheme,
or had this child not vaccinated at all. An
alternative vaccination scheme was deﬁned as:
delayed vaccination scheme or alternative vac-
cine composition (e.g., omitting the pertussis
component from the diphtheria/pertussis/tet-
anus/polio vaccine).
We asked parents if their child had ever used
antibiotics (yes/no); whether the child had been
exposed to environmental tobacco smoke (ETS)
for more than 1 h/wk (yes/no) and if they had
pets in the house at any time (yes/no). Breast-
feeding during the ﬁrst 4 months was categorized
as exclusive, non-exclusive and never. We
deﬁned exclusive as breastfeeding without any
artiﬁcial feeding and/or supplemental feeding.
Consumption of organic bananas (fresh) (yes/no)
and organic fruit (jar) (yes/no) were used as
indicator variables for choice for organic foods
when starting supplemental feeding, because
these were the foods most used in the ﬁrst
7 months.
Results
In total, 2834 pregnant women were included in
the KOALA study, of whom 491 through
alternative recruitment channels. The recruit-
ment questionnaire was ﬁlled in by 3723 PPGP
(candidate population) participants that do not
participate and by 2329 of 2343 PPGP partici-
pants that actually participate in the KOALA
study; the same information was present for all
491 alternative participants. As shown in
Table 1, the percentage of parents with allergic
history is higher in the participants compared
with non-participants: 66.5% of the newborns
recruited from the PPGP study and 73.5% of
alternative participants have at least one parent
with allergic history, whereas in the non-partic-
ipants (PPGP participants not willing to partici-
pate in the KOALA study) this is 60.0%. A
similar ﬁnding was apparent for parental
asthma: 29.2% of the newborns recruited from
Table 1. Characteristics of KOALA non-participants (n ¼ 3723) and participants (n ¼ 2343) from candidates of pregnancy-related pelvic girdle pain (PPGP) study,
and of KOALA alternative participants (n ¼ 491)
Candidates from PPGP study Alternative recruitment channels
Non-KOALA n/N (%) KOALA conventional n/N (%) KOALA alternative n/N (%)
Parental allergy 2156/3723 (60.0) 1548/2329 (66.5) 361/491 (73.5)
Parental asthma 857/3723 (23.0) 680/2329 (29.2) 127/491 (25.9)
Maternal age (mean, yr) 31.4 31.7 33.7
Maternal education
Primary school 21/3640 (1.0) 3/2295 (0.0) 2/489 (0.0)
Preparatory vocational or lower general secondary education 544/3640 (15.0) 364/2295 (15.9) 16/489 (3.3)
Vocational education 1277/3640 (35.1) 703/2295 (30.6) 52/489 (10.6)
Higher general secondary or pre-university education 409/3640 (11.2) 251/2295 (10.9) 51/489 (10.4)
Higher vocational or academic education 1212/3640 (33.3) 981/2295 (42.7) 357/489 (73.0)
Other 177/3640 (4.9) 93/2295 (4.0) 11/489 (2.2)
Lifestyle
Smoking during pregnancy 428/3671 (11.7) 192/2314 (8.3) 6/491 (1.2)
Different dietary habits 147/3532 (4.2) 151/2310 (6.5) 358/488 (73.4)
Lifestyle intention
Intention to restricted use of medication 224/3543 (6.3) 171/2317 (7.4) 308/489 (63.0)
Intention to lower vaccination uptake 105/3541 (3.0) 84/2313 (3.6) 229/489 (46.7)
Intention to breastfeed 2252/3540 (63.6) 1638/2309 (70.9) 457/489 (93.4)
Kummeling et al.
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the PPGP study and 25.9% in the alternative
group have at least one parent with asthmatic
history, whereas in the non-participants this is
23.0%. KOALA participants and non-partici-
pants are of equal age (31.7 and 31.4 yr);
alternative mothers are slightly older (33.7 yr).
The KOALA participants more often had higher
education compared with non-participants:
42.7% vs. 33.3%; in the alternative participants
this is far more (73.0%). The KOALA partici-
pants have slightly diﬀerent lifestyles compared
with non-participants, notably with respect to
the intention to breastfeed (70.9% vs. 63.6%); in
the alternative group the intention to breastfeed
is far higher (93.4%). Smoking during pregnancy
also seems to diﬀer considerably among the three
groups, with the lowest prevalence in the alter-
native group (1%).
Child characteristics from the 3 and 7 months
questionnaires of the conventional and alternat-
ive KOALA participants over the ﬁrst 7 months
of life are presented in Table 2.
A smaller proportion of alternative families
had no older siblings compared with conven-
tional families (35.0% vs. 46%). In alternative
families, conventional vaccinations schemes and
antibiotic use were less frequent (53.6% vs.
95.1%, and 13.8% vs. 24.1% respectively) and
fewer children had been exposed to ETS (2.1%
vs. 14.0%). Almost half of participants in both
subcohorts had at least one pet in the home.
Exclusive breastfeeding over the ﬁrst 4 months
was given in a considerably larger proportion of
the alternative subcohort (60.3% vs. 23.0%). Of
children that had consumed bananas and fruit in
jars, these food products had an organic origin in
56.3% and 64.1%, respectively, of the alternative
subcohort, but only 5.4% and 7.8%, respectively,
of the conventional participants.
Discussion
The KOALA Birth Cohort Study has succeeded
in recruiting a large population of participants
(n ¼ 2834) with various lifestyle choices. There-
fore, we have a fairly large contrast in exposure
to dietary habits (including breastfeeding,
organic foods and vegetarian diet), vaccination
schemes and/or antibiotic use in the ﬁrst 2 yr of
life, a period when exposure to these exposures
may inﬂuence the development of the immune
system.
Another strength of this study is the large
number of infants of which faecal samples (n ¼
1176) have been collected because previous
studies on intestinal gut ﬂora and atopy were
all based upon much smaller populations (13, 22–
24). Finally, other unique features of our study
are the large number of children with capillary
blood samples at age 1 yr and large proportion
of participants that have consented with genetic
studies.
It is well known that families with allergic
complaints tend to be over-represented in studies
on the etiology of atopy. The diﬀerence between
the participants and non-participants may be
explained by self-selection, because people with a
positive family history of allergic disease will
tend to be more interested in participating in a
study on health-related topics. Also, the health-
conscious lifestyle in the alternative group may
be associated with greater willingness to report
diseases in general, and consequently with over-
reporting of allergic complaints. Yet another
possible explanation for the higher prevalence of
atopic family history in the alternative group is
that people choose their alternative lifestyle
partly for the reason of their allergic disease.
The latter notion stresses the need for stratiﬁca-
tion on family history in the statistical analysis,
to avoid confounding between family history and
lifestyle in our study as well as in other cohort
studies.
Mid 2006 we expect to report our ﬁrst results
on the relationship between the various expo-
sures in early life and childhood atopy.
Table 2. Child characteristics of the conventional (N ¼ 2343) and alternative
subcohort (N ¼ 491) in the KOALA Birth Cohort Study over the first 7 months
after birth
Conventional
subcohort
n/N (%)
Alternative
subcohort
n/N (%)
Number of older siblings
No siblings 1023/2221 (46.1) 170/486 (35.0)
One older sibling 901/2221 (40.6) 209/486 (43.0)
Two older siblings 286/2221 (12.9) 103/486 (21.2)
Three or more older siblings 11/2221 (0.5) 4/486 (0.8)
Vaccinations
Conventional 2025/2130 (95.1) 253/472 (53.6)
Alternative scheme 67/2130 (3.1) 73/472 (15.5)
None 38/2130 (1.8) 146/472 (30.9)
Antibiotics ever used
Yes 498/2064 (24.1) 64/464 (13.8)
Exposure to household environmental tobacco smoke >1 hr/week
Yes 293/2086 (14.0) 10/471 (2.1)
Pets in the home at any time
Yes 984/2138 (46.0) 217/476 (45.6)
Breastfeeding during first 4 months
Exclusive 419/1823 (23.0) 261/433 (60.3)
Non-exclusive 498/1823 (27.3) 127/433 (29.3)
Never 906/1823 (49.7) 45/433 (10.4)
Organic fruit – fresh (banana)
Yes 77/1413 (5.4) 206/366 (56.3)
Organic fruit – jar
Yes 121/1543 (7.8) 177/276 (64.1)
 Breast feeding with supplemental liquids or solid foods.
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